NAD-ME Antikörper (AA 26-584)
Kurzübersicht für NAD-ME Antikörper (AA 26-584) (ABIN7873011)
Target
Alle NAD-ME Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 26-584
-
Verwendungszweck
- ME2 Antibody / NAD-ME
-
Aufreinigung
- Affinity purified
-
Immunogen
- Recombinant human protein (amino acids K26-E584) was used as the immunogen for the ME2 antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal dilution of the ME2 antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- After reconstitution, the ME2 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- NAD-ME (NAD Dependent Malate Dehydrogenase (NAD-ME))
-
Andere Bezeichnung
- ME2
-
Hintergrund
- NAD-dependent malic enzyme, mitochondrial is a protein that in humans is encoded by the ME2 gene. It is mapped to 18q21.2. This gene encodes a mitochondrial NAD-dependent malic enzyme, a homotetrameric protein, that catalyzes the oxidative decarboxylation of malate to pyruvate. It had previously been weakly linked to a syndrome known as Friedreich ataxia that has since been shown to be the result of mutation in a completely different gene. Certain single-nucleotide polymorphism haplotypes of this gene have been shown to increase the risk for idiopathic generalized epilepsy. Alternatively spliced transcript variants encoding different isoforms found for this gene.
-
UniProt
- P23368
-
Pathways
- Production of Molecular Mediator of Immune Response
Target
-